Skip to Content

Filter by:

Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.


Future innovations in health care and prevention require research across a full spectrum of biomedical science, from basic and translational research to implementation science and comparative effectiveness research. 

AAMC advocates for funding and appropriate regulation by major federal agencies and organizations supporting this research, including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Department of Veterans Affairs (VA).

Ensuring a sustainable research mission is essential to achieve long-term health priorities, develop new therapeutics and preventive measures, focus on patient-centered outcomes, and reduce health disparities. 

We also work to ensure the integrity of biomedical research, especially research involving human subjects, including privacy protections and management of financial conflicts of interest.


Responsible Conduct of Research
Research with AnimalsStem Cell Research and Regenerative Medicine

News and Updates

House Veterans’ Affairs Committee Holds Hearing on FY 19 Budget Request

February 16, 2018

The House Veterans’ Affairs Committee held a Feb. 15 hearing on the Department of Veterans Affairs (VA) Budget Request for FY 2019.

Senate Confirms USPTO Under Secretary of Commerce for Intellectual Property and Director

February 9, 2018

The Senate Feb. 5 unanimously confirmed (94-0) Andrei Iancu to become U.S. Patent and Trademark Office Under Secretary of Commerce for Intellectual Property and Director.

AAMC Submits Comments to the FDA on the Review of Existing Regulations and Requirements

February 9, 2018

The AAMC Feb 5 submitted a letter [PC1] to the Food and Drug Administration (FDA) in response to a request for comments on ways to identify regulations and related paperwork requirements that could be “modified, repealed, or replaced” under Presidential Executive Order (EO) 13771, “Reducing Regulation and Controlling Regulatory Costs” and EO 13777, “Enforcing the Regulatory Reform Agenda” [see Washington Highlights, Feb. 10, 2017 and March 3, 2017].

Lawmakers End Shutdown and Extend CHIP, But Fail to Negotiate DACA Agreement

January 26, 2018

Following a three day shutdown of the federal government, President Trump Jan. 22 signed another continuing resolution (P.L. 115-120, CR) passed by Congress earlier that day to reopen federal agencies through Feb. 8.

AAMC Comments on NIH Office of Disease Prevention Strategic Plan

January 26, 2018

The AAMC Jan. 19 submitted comments in response to the National Institutes of Health (NIH) Office of Disease Prevention (ODP) request for information on the ODP's strategic plan for fiscal years (FYs) 2019-2023.

On Government Affairs

Research Spectrum

Testimony and Correspondence